These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 12820887)

  • 1. Communication between the nucleotide binding domains of P-glycoprotein occurs via conformational changes that involve residue 508.
    Gabriel MP; Storm J; Rothnie A; Taylor AM; Linton KJ; Kerr ID; Callaghan R
    Biochemistry; 2003 Jul; 42(25):7780-9. PubMed ID: 12820887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2007 Aug; 46(32):9328-36. PubMed ID: 17636884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state.
    Ramachandra M; Ambudkar SV; Chen D; Hrycyna CA; Dey S; Gottesman MM; Pastan I
    Biochemistry; 1998 Apr; 37(14):5010-9. PubMed ID: 9538020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
    Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
    Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The coupling mechanism of P-glycoprotein involves residue L339 in the sixth membrane spanning segment.
    Rothnie A; Storm J; McMahon R; Taylor A; Kerr ID; Callaghan R
    FEBS Lett; 2005 Jul; 579(18):3984-90. PubMed ID: 16004994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the "occluded nucleotide conformation" of P-glycoprotein in the catalytic pathway.
    Tombline G; Muharemagić A; White LB; Senior AE
    Biochemistry; 2005 Sep; 44(38):12879-86. PubMed ID: 16171403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The power of the pump: mechanisms of action of P-glycoprotein (ABCB1).
    Ambudkar SV; Kim IW; Sauna ZE
    Eur J Pharm Sci; 2006 Apr; 27(5):392-400. PubMed ID: 16352426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosolic region of TM6 in P-glycoprotein: topographical analysis and functional perturbation by site directed labeling.
    Storm J; Modok S; O'Mara ML; Tieleman DP; Kerr ID; Callaghan R
    Biochemistry; 2008 Mar; 47(12):3615-24. PubMed ID: 18303860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residue G346 in transmembrane segment six is involved in inter-domain communication in P-glycoprotein.
    Storm J; O'Mara ML; Crowley EH; Peall J; Tieleman DP; Kerr ID; Callaghan R
    Biochemistry; 2007 Sep; 46(35):9899-910. PubMed ID: 17696319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer.
    Stratford FL; Ramjeesingh M; Cheung JC; Huan LJ; Bear CE
    Biochem J; 2007 Jan; 401(2):581-6. PubMed ID: 16989640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of P-glycoprotein ATPase by analogues of tetramethylrosamine: coupling of drug binding at the "R" site to the ATP hydrolysis transition state.
    Tombline G; Donnelly DJ; Holt JJ; You Y; Ye M; Gannon MK; Nygren CL; Detty MR
    Biochemistry; 2006 Jul; 45(26):8034-47. PubMed ID: 16800628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP hydrolysis promotes interactions between the extracellular ends of transmembrane segments 1 and 11 of human multidrug resistance P-glycoprotein.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2005 Aug; 44(30):10250-8. PubMed ID: 16042402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
    Eckford PD; Sharom FJ
    Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the role of the invariant carboxylate residues E552 and E1197 in the catalytic activity of Abcb1a (mouse Mdr3).
    Carrier I; Gros P
    FEBS J; 2008 Jul; 275(13):3312-24. PubMed ID: 18489584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The drug-binding pocket of the human multidrug resistance P-glycoprotein is accessible to the aqueous medium.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2004 Sep; 43(38):12081-9. PubMed ID: 15379547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residues responsible for the asymmetric function of the nucleotide binding domains of multidrug resistance protein 1.
    Qin L; Zheng J; Grant CE; Jia Z; Cole SP; Deeley RG
    Biochemistry; 2008 Dec; 47(52):13952-65. PubMed ID: 19063607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the three-dimensional structure of human P-glycoprotein in absence of ATP by computational techniques embodying crosslinking data: insight into the mechanism of ligand migration and binding sites.
    Vandevuer S; Van Bambeke F; Tulkens PM; Prévost M
    Proteins; 2006 May; 63(3):466-78. PubMed ID: 16463278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular understanding of the catalytic cycle of the nucleotide-binding domain of the ABC transporter HlyB.
    Zaitseva J; Jenewein S; Oswald C; Jumpertz T; Holland IB; Schmitt L
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):990-5. PubMed ID: 16246029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric modulation of the human P-glycoprotein involves conformational changes mimicking catalytic transition intermediates.
    Ghosh P; Moitra K; Maki N; Dey S
    Arch Biochem Biophys; 2006 Jun; 450(1):100-12. PubMed ID: 16624245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating the folding of P-glycoprotein and cystic fibrosis transmembrane conductance regulator truncation mutants with pharmacological chaperones.
    Wang Y; Loo TW; Bartlett MC; Clarke DM
    Mol Pharmacol; 2007 Mar; 71(3):751-8. PubMed ID: 17132688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.